Compass Therapeutics, Inc.
CMPX
$2.25
-$0.01-0.44%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -18.41% | -23.45% | -34.66% | -37.79% | -31.29% |
| Total Depreciation and Amortization | -4.50% | -10.76% | -16.03% | -21.54% | -16.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.81% | 15.34% | -3.10% | 40.23% | 95.59% |
| Change in Net Operating Assets | -20.55% | 184.78% | 321.61% | 242.88% | 380.16% |
| Cash from Operations | -23.99% | -20.44% | -9.56% | 6.24% | -5.44% |
| Capital Expenditure | -327.42% | -43.55% | 43.18% | 52.83% | -226.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -230.47% | -206.17% | -299.25% | -297.34% | 92.80% |
| Cash from Investing | -231.17% | -206.41% | -299.49% | -297.68% | 92.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 668.92% | 661.88% | -100.00% |
| Repurchase of Common Stock | 23.05% | 23.05% | -342.67% | -208.81% | -208.81% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -863,900.00% | -1,490.79% | -1,487.50% | 100.00% |
| Cash from Financing | 14,785.95% | 14,802.09% | 647.54% | 643.61% | -105.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 213.36% | -21.30% | -164.77% | 35.55% | 3,090.48% |